Supernus Pharmaceuticals (SUPN) Current Taxes (2016 - 2020)

Supernus Pharmaceuticals (SUPN) has 5 years of Current Taxes data on file, last reported at $25.1 million in Q2 2020.

• Current Taxes for Q2 2020 came in at $25.1 million, up 836.87% year-over-year; the trailing twelve-month figure through Jun 2020 was $25.1 million (up 836.87% YoY), and the FY2019 annual result was $2.4 million, down 80.26% from the prior year.
• Current Taxes climbed to $25.1 million in Q2 2020 per SUPN's latest filing, from $9.1 million in the prior quarter.
• Over five years, Current Taxes peaked at $25.1 million in Q2 2020 and troughed at $7000.0 in Q4 2016.
• A 5-year average of $8.9 million and a median of $7.5 million in 2017 frame the typical range for Current Taxes.
• The sharpest annual moves came in 2017 and 2019: Current Taxes soared 227585.71% in 2017, then tumbled 80.26% in 2019.
• A 5-year view of Current Taxes shows it stood at $7000.0 in 2016, then soared by 227585.71% to $15.9 million in 2017, then fell by 22.34% to $12.4 million in 2018, then plunged by 80.26% to $2.4 million in 2019, then surged by 925.46% to $25.1 million in 2020.
• Business Quant data shows SUPN's Current Taxes at $25.1 million in Q2 2020, $9.1 million in Q1 2020, and $2.4 million in Q4 2019.